This EuroIntervention issue aligned with PCR London Valves includes an overview of the EAPCI’s 2024 Core Curriculum on Percutaneous Valvular and Structural Heart Disease Interventions in collaboration with the EACVI and the WG CVS of the ESC; a mini-focus on redo-TAVI including articles on SAPIEN 3 in degenerated CoreValve/Evolut; SAPIEN 3 in degenerated ACURATE neo2; a research correspondence on evaluating redo-TAVI in bicuspid valves; original research on outcomes in relation to low-flow, low-gradient aortic stenosis after TAVI; an exploration of predictors and clinical effects of worsening left ventricular ejection fraction after M-TEER; a description of the MitraCut procedure to prevent LVOT obstruction in TA-TMVR; a research correspondence on temporal trends in T-TEER; a debate on whether TAVI patients with bystander CAD should receive PCI; news from the EAPCI; and more...
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)